tiprankstipranks
Luye Pharma Group Ltd. (LYPHF)
OTHER OTC:LYPHF
US Market
LYPHF
Luye Pharma Group
RESEARCH TOOLSreports
Want to see LYPHF full AI Analyst Report?

Luye Pharma Group (LYPHF) Financial Statements

3 Followers

Luye Pharma Group Financial Overview

Luye Pharma Group's market cap is currently $1.27B. The company's EPS TTM is $0.1544; its P/E ratio is 8.27; Luye Pharma Group is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 6.15B¥ 6.06B¥ 6.14B¥ 5.98B¥ 5.20B
Gross Profit¥ 4.05B¥ 4.04B¥ 4.20B¥ 4.14B¥ 3.40B
Operating Income¥ 1.21B¥ 1.15B¥ 917.88M¥ 880.62M¥ 437.96M
EBITDA¥ 2.03B¥ 1.79B¥ 2.08B¥ 1.81B¥ 906.88M
Net Income¥ 602.73M¥ 471.89M¥ 532.61M¥ 604.81M¥ -134.39M
Balance Sheet
Cash & Short-Term Investments¥ 8.88B¥ 6.50B¥ 6.11B¥ 5.54B¥ 5.51B
Total Assets¥ 32.84B¥ 29.61B¥ 25.49B¥ 24.25B¥ 22.58B
Total Debt¥ 9.42B¥ 10.32B¥ 8.42B¥ 9.10B¥ 9.49B
Net Debt¥ 4.92B¥ 5.38B¥ 5.18B¥ 6.78B¥ 7.05B
Total Liabilities¥ 14.19B¥ 13.86B¥ 11.96B¥ 13.21B¥ 13.47B
Stockholders' Equity¥ 16.08B¥ 14.15B¥ 12.53B¥ 10.18B¥ 8.49B
Cash Flow
Free Cash Flow¥ 780.44M¥ -1.54B¥ 430.23M¥ 490.14M¥ -1.36B
Operating Cash Flow¥ 1.78B¥ 167.76M¥ 1.60B¥ 1.65B¥ 182.37M
Investing Cash Flow¥ -3.99B¥ -1.47B¥ -1.42B¥ -1.66B¥ -3.44B
Financing Cash Flow¥ 1.79B¥ 2.96B¥ 841.60M¥ 54.15M¥ 1.88B
Currency in CNY

Luye Pharma Group Earnings and Revenue History

Income Statement >

Luye Pharma Group Debt to Assets

Balance Sheet >

Luye Pharma Group Cash Flow

Cash Flow >

Luye Pharma Group Forecast EPS vs Actual EPS

Earnings >